Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-003756
Filing Date
2017-01-13
Accepted
2017-01-13 19:47:33
Documents
1
Period of Report
2017-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6998
  Complete submission text file 0001209191-17-003756.txt   8578
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Issuer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address
EASTLAND JULIA MARIE (Reporting) CIK: 0001500189 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 17528915